Mark Curtis
Optometrist · Warrensburg, MONPI 1700840378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $525 and has fallen 75.4% since, to $129 in 2025.
Across 72 payments — averaging $26.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$413
- Bausch & Lomb, A Division Of Bausch Health US, LLC$377
- Johnson & Johnson Vision Care, Inc.$340
- Alcon$144
- LKC Technologies, Inc.$127
- Menicon America Inc$120
- plus $419 from 10 others
Across 9 payments — averaging $6247.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch & Lomb Americas Inc.$40K
- Johnson & Johnson Vision Care, Inc.$16K
What the payments were for
- Food & beverage$1,89297%
- Entertainment$493%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 15 | $413 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $377 |
| Johnson & Johnson Vision Care, Inc. | 20 | $340 |
| Alcon | 7 | $144 |
| LKC Technologies, Inc. | 1 | $127 |
| Menicon America Inc | 1 | $120 |
| Coopervision Inc. | 5 | $104 |
| Oyster Point Pharma, Inc. | 2 | $66 |
| Tarsus Pharmaceuticals, Inc. | 2 | $55 |
| ABB Con-cise Optical Group LLC | 1 | $54 |
| Optos, Inc. | 2 | $49 |
| Sun Pharmaceutical Industries Inc. | 1 | $34 |
| AbbVie | 1 | $16 |
| Maculogix, Inc. | 1 | $14 |
| Novartis | 1 | $14 |
| Carl Zeiss Meditec USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Miru$120
- INFUSE$108
How this compares
$1,941 in reported general payments places this provider in the 70th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 122 | $1,362 |
| Prednisolone Acetate | 18 | $496 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 30 | $447 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Warrensburg
- Jason LakeWarrensburg$18K
- Andrew BiondoKirkwood$300K
- John McGrealSaint Louis$126K
- Alana KellerWildwood$94K
- Sarah HubbardChesterfield$91K
- Ariel CerenzieSaint Louis$76K
- Geoffrey PowellKansas City$55K
- Thomas HobbsSedalia$53K
- Heather WebsterColumbia$52K
- Sean MulqueenyCreve Coeur$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.